Clinical Trial Update: A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 trial of IM-101 in adults with generalized and ocular myasthenia gravis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• IM-101

Snippet

Sponsor: ImmunAbs Inc. | Conditions: Myasthenia Gravis | Phase 1, Phase 2 | Status: RECRUITING